Search for:
Search for:
Healthcare Professionals
Publications
News
EspaƱol
Contact
Magazine
Radio
Get Educated
What is MS?
A chronic neurological disorder that affects the central nervous system, comprised of the brain...
More Details
Educational Materials
Common Questions
Lending Library
Symptoms
Treatment Options
Additional Resources
Research
MS Awareness Month
Donate
Get Help
Health & Wellness Program
Get educational materials and referrals, as well as the opportunity to participate in various...
Learn More
Grants & Programs
Awareness Campaigns
Support Groups
Events
Lending Library
Additional Resources
Get Involved
MS Awareness Month
An annual, nationwide campaign with goals to promote an understanding of MS, and to assist those...
Learn More
Advocacy
Buy from Partners
Volunteer
Businesses
MS Research Trials
Outreach
Awareness Campaigns
Host an Event
Events
Test Flyout
lorem ipsum dolor sit lorem ipsum dolor sit lorem ipsum dolor sit lorem ipsum dolor sit lorem...
Learn More
Events Calendar
Health & Wellness
Fundraisers
Support
Web & Teleconferences
MS Education
Host an Event
About Us
Programs & Grants
More Details
Overview
Press Room
Leadership
Financial Statements
Our Mission
Careers at MS Focus
Affiliations
News & Features
MS Focus At Sea
MS Focus At Sea offers educational programs, opportunities to meet old and new friends, and adventures for every...
/Events/MSF-Events/MSFocus-Cruise-For-A-Cause
Brighter Tomorrow Grant
The Brighter Tomorrow Grant allows MS Focus to makes dreams come true for people with MS across...
/Get-Help/MSF-Programs-Grants/Brighter-Tomorrow-Grant
Shop
Privacy
Terms of Use
Site Map
Survey finds MS relapse is underreported
November 07, 2017
Two surveys suggest patient-reported multiple sclerosis relapse rates may be higher than thought. The surveys found that approximately one in every two patients experiencing a relapse do not always report it to their healthcare provider.
The first survey, “Relapse Prevalence, Symptoms, and Health Care Engagement: Insights from Patients with Multiple Sclerosis from the Multiple Sclerosis in America 2017 Survey” found that:
46.9 percent of respondents with relapses said they always or often contact their healthcare provider during a relapse; 45.8 percent said they sometimes or rarely contact their healthcare provider during a relapse; and 7.3 percent said they never contact their healthcare provider during a relapse.
Common reasons for patients not engaging their healthcare provider during a relapse were: relapse is not severe enough (57.9 percent), healthcare provider is unhelpful or didn’t tell me I should (30.9 percent), medications are ineffective or not well tolerated (25.6 percent), preference to manage alone (24.4 percent), financial or insurance barriers (16.1 percent), or had medication on-hand (10 percent).
More frequent patient engagement of an healthcare provider during a relapse was associated with lower relapse frequency.
In addition, patients were more satisfied with both their provider and their overall treatment plan when healthcare provider follow-up occurred within one month of reporting of the relapse.
The second study, “Understanding Patient Underreporting of MS Relapses: Insights from a 2017 Survey of Patients with Multiple Sclerosis” found that while most patients believe it is at least as important (if not more important) to treat relapses as their MS, half said they do not always contact their physician when they suspect they are experiencing a relapse. A majority of those who do not always report their suspected relapses cited their reason for not doing so as believing the relapse would resolve on its own and didn’t need to be treated.
Patients who always reported suspected relapses were more likely to:
strongly agree that their doctor has spent time educating them about the signs and symptoms that could indicate a relapse (54 percent);
state that it is very important to monitor for signs and symptoms of a relapse (83 percent), report symptoms regardless of severity (83 percent), and seek treatment for their relapse (80 percent); and
be very satisfied with prior steroid therapy (39 percent) and be willing to be treated again with IV steroids (94 percent).
The findings were presented at the Joint ECTRIMS-ACTRIMS Meeting in Paris, France.
MS Focus Lending Library
Books, DVDs, and CDs are available for loan, by mail across the United States.
Learn more